Next Article in Journal
Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pGX9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial
Next Article in Special Issue
Research Progress on Varicella-Zoster Virus Vaccines
Previous Article in Journal
Construction and Preclinical Evaluation of a Recombinant Attenuated Measles Vaccine Candidate of the H1a Genotype
Previous Article in Special Issue
Varicella and Zoster Vaccination Strategies in Immunosuppressed Pediatric Transplant Recipients
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Review

Article Versions Notes

Vaccines 2025, 13(6), 572; https://doi.org/10.3390/vaccines13060572
Action Date Notes Link
article html file updated 15 September 2025 07:07 CEST Update https://www.mdpi.com/2076-393X/13/6/572/html
article html file updated 28 August 2025 07:59 CEST Update -
article html file updated 25 June 2025 06:15 CEST Update -
article html file updated 27 May 2025 10:44 CEST Original file -
article pdf uploaded. 27 May 2025 10:42 CEST Version of Record https://www.mdpi.com/2076-393X/13/6/572/pdf
article xml uploaded. 27 May 2025 10:42 CEST Update https://www.mdpi.com/2076-393X/13/6/572/xml
article xml file uploaded 27 May 2025 10:42 CEST Original file -
Back to TopTop